Pre-Seed, Seed, Series A
$1.0M – $20.0M
$12.0B
12+ companies
12 partners
Investment Thesis
ARCH is committed to building enduring companies that leverage advancements in technology and biology, with deep expertise in cell therapy and biotechnology.
Meet the Team
Industry Focus
Invests In
Portfolio Companies (12)
Other
Beam Therapeutics
Lyell Immunopharma
Halo Top
Calm
Codiak BioSciences, Inc. (CIK 0001659352)
SEC Form D filing mentioning ARCH Venture Partners
ARCH Venture Fund VIII Overage, L.P. (CIK 0001617237)
SEC Form D filing mentioning ARCH Venture Partners
ARCH Venture Fund IX Overage, L.P. (CIK 0001666307)
SEC Form D filing mentioning ARCH Venture Partners
ARCH Venture Fund XII, L.P. (CIK 0001906837)
SEC Form D filing mentioning ARCH Venture Partners
ARCH Venture Fund IX, L.P. (CIK 0001666306)
SEC Form D filing mentioning ARCH Venture Partners
ARCH Venture Fund XI, L.P. (CIK 0001831802)
SEC Form D filing mentioning ARCH Venture Partners
- •Raising at Pre-Seed, Seed, Series A? You're squarely in their sweet spot.
- •Lead with your fit in Healthcare, Deep Tech, Other — the sectors they actively back.
- •Size your ask to their typical $1.0M – $20.0M check.
- •warm intro preferred
- •Address your outreach to a specific partner, such as Melanie Simms, Director of Operations.
- •A warm introduction beats a cold email. Get matched and request an intro.
Featured In
Browse More Investors
Fundraising resources
Frequently Asked Questions
See if ARCH Venture Partners is a match for your startup
Upload your pitch deck to see how well you match with ARCH Venture Partners and 10,000+ other investors.
Is this your profile? Request a correction or removal